IC50 for treatment with erlotinib, gefitinib or vandetanib in parental CALU-3 and HCT116 cell lines (WT) and their TKI-resistant derivatives (ERL-R, GEF-R, VAN-R).
收藏Figshare2015-12-02 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/_IC50_for_treatment_with_erlotinib_gefitinib_or_vandetanib_in_parental_CALU_3_and_HCT116_cell_lines_WT_and_their_TKI_resistant_derivatives_ERL_R_GEF_R_VAN_R_/375238
下载链接
链接失效反馈官方服务：
资源简介：
IC50 for treatment with erlotinib, gefitinib or vandetanib in parental CALU-3 and HCT116 cell lines (WT) and their TKI-resistant derivatives (ERL-R, GEF-R, VAN-R).
创建时间：
2015-12-02
